Fourlanos, Spiros

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors

Danne, T., Garg, S., Peters, A. L., Buse, J. B., Mathieu, C., Pettus, J. H., Alexander, C. M., Battelino, T., Ampudia-Blasco, F. J., Bode, B. W., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 379

SGLT2 inhibitors increase the risk of diabetic ketoacidosis developing in the community and during hospital admission

Hamblin, P. S., Wong, R., Ekinci, E. I., Fourlanos, S., Shah, S., Jones, A. R., Hare, M. J. L., Calder, G. L., Epa, D. S., George, E. M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 126

Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial

McAuley, S. A., Trawley, S., Vogrin, S., Ward, G. M., Fourlanos, S., Grills, C. A., Lee, M. H., Alipoor, A. M., O’Neal, D. N., O’Regan, N. A., et al. (2022) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 117

Early intervention for diabetes in medical and surgical inpatients decreases hyperglycemia and hospital-acquired infections: A cluster randomized trial

Kyi, M., Colman, P. G., Wraight, P. R., Reid, J., Gorelik, A., Galligan, A., Kumar, S., Rowan, L. M., Marley, K. A., Nankervis, A. J., et al. (2019) · Diabetes Care

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research

Cited by 86

Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes

Price, S. A., Gorelik, A., Fourlanos, S., Colman, P. G., & Wentworth, J. M. (2014) · Obesity Research & Clinical Practice

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 77

Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes

Lomax, K. E., Taplin, C. E., Abraham, M. B., Smith, G. J., Haynes, A., Zomer, E., Ellis, K. L., Clapin, H., Zoungas, S., Jenkins, A. J., et al. (2024) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 20

Body mass index correlates with ischemic heart disease and albuminuria in long-standing type 2 diabetes

Wentworth, J. M., Fourlanos, S., & Colman, P. G. (2012) · Diabetes Research and Clinical Practice

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 16

Metabolic outcomes in patients with diabetes mellitus administered SGLT2 inhibitors immediately before emergency or elective surgery: single centre experience and recommendations

Wang, R., Kave, B., McIlroy, E., Kyi, M., Colman, P. G., & Fourlanos, S. (2021) · British Journal of Anaesthesia

Diabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 10